Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVACINCAPTAD PEGOL vs ZILUCOPLAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVACINCAPTAD PEGOL vs ZILUCOPLAN: Safety Overview

Metric AVACINCAPTAD PEGOL ZILUCOPLAN
Total FAERS Reports 202 441
Deaths Reported 3 23
Death Rate 1.5% 5.2%
Hospitalizations 2 163
Average Patient Age 82.3 yrs 58.8 yrs
% Female Patients 61.9% 53.6%
FDA Approval Date Aug 4, 2023 Oct 17, 2023
Manufacturer Astellas Pharma US, Inc. UCB, Inc.
Route INTRAVITREAL SUBCUTANEOUS
Marketing Status Prescription Prescription